Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 10 of 26 items for :

  • "late effects" x
Clear All
J Gebauer Department of Internal Medicine I, University Hospital of Schleswig-Holstein, Campus Luebeck and Institute for Endocrinology and Diabetes, University of Luebeck, Luebeck, Germany

Search for other papers by J Gebauer in
Google Scholar
PubMed Close
,
R Skinner Department of Paediatric and Adolescent Haematology and Oncology and Children’s BMT Unit, Great North Children’s Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK

Search for other papers by R Skinner in
Google Scholar
PubMed Close
,
R Haupt DOPO Clinic, Department of Hematology/Oncolgy, IRCCS Istituto Giannina Gaslini, Genova, Italy

Search for other papers by R Haupt in
Google Scholar
PubMed Close
,
L Kremer Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Amsterdam UMC, Emma’s Children’s Hospital, Amsterdam, The Netherlands

Search for other papers by L Kremer in
Google Scholar
PubMed Close
,
H van der Pal Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands

Search for other papers by H van der Pal in
Google Scholar
PubMed Close
,
G Michel Department of Health Sciences and Medicine, University of Lucerne, Luzern, Switzerland

Search for other papers by G Michel in
Google Scholar
PubMed Close
,
G T Armstrong Department of Epidemiology and Cancer Control, St. Jude Children’s Research Hospital, Memphis, Tennessee, USA

Search for other papers by G T Armstrong in
Google Scholar
PubMed Close
,
M M Hudson Department of Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee, USA

Search for other papers by M M Hudson in
Google Scholar
PubMed Close
,
L Hjorth Department of Clinical Sciences Lund, Paediatrics, Lund University, Skane University Hospital, Lund, Sweden

Search for other papers by L Hjorth in
Google Scholar
PubMed Close
,
H Lehnert Paris Lodron University of Salzburg, Salzburg, Austria

Search for other papers by H Lehnert in
Google Scholar
PubMed Close
, and
T Langer Pediatric Hematology and Oncology, University Hospital of Schleswig-Holstein, Campus Luebeck, Luebeck, Germany

Search for other papers by T Langer in
Google Scholar
PubMed Close

-term survivors suffer from treatment-related late effects, which may occur years to decades after the completion of therapy ( 2 ). Increasing knowledge and recognition of these sequelae resulted in, whenever possible, a reduction or even elimination of

Article Type:
Review Article
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-22-0083
Volume/Issue:
Volume 11: Issue 9
Open access
Izabelle Lövgren Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK

Search for other papers by Izabelle Lövgren in
Google Scholar
PubMed Close
,
Azadeh Abravan Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, UK

Search for other papers by Azadeh Abravan in
Google Scholar
PubMed Close
,
Abigail Bryce-Atkinson Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK

Search for other papers by Abigail Bryce-Atkinson in
Google Scholar
PubMed Close
, and
Marcel van Herk Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, UK

Search for other papers by Marcel van Herk in
Google Scholar
PubMed Close

efficacy and detrimental side effects, such as secondary neoplasms and endocrine deficiencies, is still needed. As the survival rate has also increased, patients are now living long enough to see these late effects. Common oncological treatments include

Article Type:
Review Article
Collections:
Pituitary and Hypothalamus
DOI:
https://doi.org/10.1530/EC-22-0298
Volume/Issue:
Volume 11: Issue 12
Open access
Sidsel Mathiesen Department of Pediatrics and Adolescent Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Sidsel Mathiesen in
Google Scholar
PubMed Close
,
Kaspar Sørensen Department of Pediatrics and Adolescent Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Kaspar Sørensen in
Google Scholar
PubMed Close
,
Marianne Ifversen Department of Pediatrics and Adolescent Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Marianne Ifversen in
Google Scholar
PubMed Close
,
Casper P Hagen Department of Growth and Reproduction, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Casper P Hagen in
Google Scholar
PubMed Close
,
Jørgen Holm Petersen Department of Growth and Reproduction, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Section of Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Jørgen Holm Petersen in
Google Scholar
PubMed Close
,
Anders Juul Department of Growth and Reproduction, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Anders Juul in
Google Scholar
PubMed Close
, and
Klaus Müller Department of Pediatrics and Adolescent Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Klaus Müller in
Google Scholar
PubMed Close

Introduction Hematopoietic stem cell transplantation (HSCT) is a potentially curative treatment for children with life-threatening hematological and immunological diseases, including high-risk leukemias, but late effects are becoming prevalent

Article Type:
Research Article
Collections:
Paediatric Endocrinology Collection
DOI:
https://doi.org/10.1530/EC-21-0154
Volume/Issue:
Volume 10: Issue 10
Open access
Judith Gebauer Department of Internal Medicine I, University Hospital Schleswig-Holstein, Luebeck, Germany

Search for other papers by Judith Gebauer in
Google Scholar
PubMed Close
and
Claire E Higham Department of Endocrinology, Christie Hospital NHS Foundation Trust, University of Manchester, and Manchester Academic Health Science Centre, Manchester, UK

Search for other papers by Claire E Higham in
Google Scholar
PubMed Close

represent a comparably small group of patients in this large cohort that have been studied for decades due to their excellent long-term survival rates and the long life span ahead of them after the end of treatment. Much knowledge about late effects is

Article Type:
Editorial
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-22-0261
Volume/Issue:
Volume 11: Issue 9
Open access
David S McLaren Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospital NHS Trust, Leeds, UK

Search for other papers by David S McLaren in
Google Scholar
PubMed Close
,
Aarani Devi Clinical Oncology, Leeds Cancer Centre, Leeds Teaching Hospital NHS Trust, Leeds, UK

Search for other papers by Aarani Devi in
Google Scholar
PubMed Close
,
Nikolaos Kyriakakis Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospital NHS Trust, Leeds, UK

Search for other papers by Nikolaos Kyriakakis in
Google Scholar
PubMed Close
,
Michelle Kwok-Williams Clinical Oncology, Leeds Cancer Centre, Leeds Teaching Hospital NHS Trust, Leeds, UK

Search for other papers by Michelle Kwok-Williams in
Google Scholar
PubMed Close
, and
Robert D Murray Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospital NHS Trust, Leeds, UK
Division of Cardiovascular and Diabetes Research, Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK

Search for other papers by Robert D Murray in
Google Scholar
PubMed Close

). Evolution of conventional XRT The paediatric population, due to their growth and development potential, is particularly sensitive to radiation-induced side effects. Competing objectives to maximise cure and minimise toxicity including late effects are

Article Type:
Review Article
Collections:
Pituitary and Hypothalamus
DOI:
https://doi.org/10.1530/EC-22-0490
Volume/Issue:
Volume 12: Issue 9
Open access
Alexander Heinzel RWTH University Hospital Aachen, Department of Nuclear Medicine, Aachen, Germany

Search for other papers by Alexander Heinzel in
Google Scholar
PubMed Close
,
Dirk Müller Institute for Health Economics and Clinical Epidemiology, University of Cologne, Cologne, Germany

Search for other papers by Dirk Müller in
Google Scholar
PubMed Close
,
Hanneke M van Santen Wilhelmina Children’s Hospital, University Medical Center Utrecht, Department of Pediatric Endocrinology, Utrecht, The Netherlands
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands

Search for other papers by Hanneke M van Santen in
Google Scholar
PubMed Close
,
Sarah C Clement Wilhelmina Children’s Hospital, University Medical Center Utrecht, Department of Pediatric Endocrinology, Utrecht, The Netherlands
Emma Children’s Hospital, Amsterdam UMC, Department of Pediatrics, Amsterdam, The Netherlands

Search for other papers by Sarah C Clement in
Google Scholar
PubMed Close
,
Arthur B Schneider University of Illinois at Chicago, Department of Medicine, Chicago, IL, USA

Search for other papers by Arthur B Schneider in
Google Scholar
PubMed Close
, and
Frederik A Verburg Erasmus MC Rotterdam, Department of Radiology & Nuclear Medicine, Rotterdam, The Netherlands
University Hospital Würzburg, Department of Nuclear Medicine, Würzburg, Germany

Search for other papers by Frederik A Verburg in
Google Scholar
PubMed Close

2018, the International Guideline Harmonization Group (IGHG) on guidelines for late effects of childhood cancer, therefore, released recommendations on surveillance for DTC in at-risk CCS ( 6 ). These guidelines stated that surveillance for DTC may be

Article Type:
Review Article
Collections:
Thyroid
DOI:
https://doi.org/10.1530/EC-22-0092
Volume/Issue:
Volume 11: Issue 12
Open access
A J Clark Endocrine Connections Editor-in-Chief, Emeritus Professor of Endocrinology, University of London, London, United Kingdom of Great Britain and Northern Ireland

Search for other papers by A J Clark in
Google Scholar
PubMed Close

review articles that relate to paediatric elements of disease and, as an example of this initiative, we are currently publishing an excellent series of articles on the ‘Late effects of cancer therapy in children’ ( https

Article Type:
Editorial
DOI:
https://doi.org/10.1530/EC-23-0051
Volume/Issue:
Volume 12: Issue 4
Open access
Luminita Nicoleta Cima Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

Search for other papers by Luminita Nicoleta Cima in
Google Scholar
PubMed Close
,
Anca Colita Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
Hematology Department, Fundeni Hospital, Bucharest, Romania

Search for other papers by Anca Colita in
Google Scholar
PubMed Close
, and
Simona Fica Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
Endocrine Department, Elias Hospital, Bucharest, Romania

Search for other papers by Simona Fica in
Google Scholar
PubMed Close

this review. Funding This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors. References 1 Brennan BM Shalet SM . Endocrine late effects after bone marrow transplant

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-17-0246
Volume/Issue:
Volume 6: Issue 8
Open access
Nikolaos Kyriakakis Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Leeds Institute for Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK

Search for other papers by Nikolaos Kyriakakis in
Google Scholar
PubMed Close
,
Marilena Giannoudi Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds, UK

Search for other papers by Marilena Giannoudi in
Google Scholar
PubMed Close
,
Satish S Kumar Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds, UK

Search for other papers by Satish S Kumar in
Google Scholar
PubMed Close
,
Khyatisha Seejore Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Leeds Institute for Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK

Search for other papers by Khyatisha Seejore in
Google Scholar
PubMed Close
,
Georgios K Dimitriadis Department of Endocrinology, King’s College Hospital NHS Foundation Trust, Denmark Hill, London, UK

Search for other papers by Georgios K Dimitriadis in
Google Scholar
PubMed Close
,
Harpal Randeva Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism (WISDEM), University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK

Search for other papers by Harpal Randeva in
Google Scholar
PubMed Close
,
Adam Glaser Pediatric Oncology, Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Leeds Institute of Medical Research, University of Leeds, UK

Search for other papers by Adam Glaser in
Google Scholar
PubMed Close
,
Michelle Kwok-Williams Clinical Oncology, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK

Search for other papers by Michelle Kwok-Williams in
Google Scholar
PubMed Close
,
Georgina Gerrard Clinical Oncology, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK

Search for other papers by Georgina Gerrard in
Google Scholar
PubMed Close
,
Carmel Loughrey Clinical Oncology, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK

Search for other papers by Carmel Loughrey in
Google Scholar
PubMed Close
,
Ahmed Al-Qaissi Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds, UK

Search for other papers by Ahmed Al-Qaissi in
Google Scholar
PubMed Close
,
Ramzi Ajjan Leeds Institute for Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK

Search for other papers by Ramzi Ajjan in
Google Scholar
PubMed Close
,
Julie Lynch Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds, UK

Search for other papers by Julie Lynch in
Google Scholar
PubMed Close
, and
Robert D Murray Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Leeds Institute for Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK

Search for other papers by Robert D Murray in
Google Scholar
PubMed Close

primary brain tumours. Individuals with a history of malignant brain tumours of both CO (age ≤ 18 years) and AO (age > 18 years) were invited to participate in the study. Patients were recruited from the adult and childhood late-effects oncology clinics at

Article Type:
Research Article
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-22-0491
Volume/Issue:
Volume 12: Issue 8
Open access
I M A A van Roessel Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands

Search for other papers by I M A A van Roessel in
Google Scholar
PubMed Close
,
J P de Graaf Dutch Pituitary Foundation, Nijkerk, The Netherlands
Department of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands
Endo-ERN European Reference Network on Rare endocrine conditions

Search for other papers by J P de Graaf in
Google Scholar
PubMed Close
,
N R Biermasz Department of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands
Endo-ERN European Reference Network on Rare endocrine conditions

Search for other papers by N R Biermasz in
Google Scholar
PubMed Close
,
E Charmandari Division of Endocrinology, Metabolism and Diabetes, First Department of Pediatrics, National and Kapodistrian University of Athens Medical School, Aghia Sophia Children's Hospital, Athens, Greece
Division of Endocrinology and Metabolism, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece

Search for other papers by E Charmandari in
Google Scholar
PubMed Close
, and
H M van Santen Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands

Search for other papers by H M van Santen in
Google Scholar
PubMed Close

of the late effects of their brain tumor treatment until they occurred and therefore did not feel prepared for these late effects. According to the patients, some doctors focus too much on survival rather than on quality of life. Patients

Article Type:
Research Article
Collections:
Pituitary and Hypothalamus
DOI:
https://doi.org/10.1530/EC-23-0147
Volume/Issue:
Volume 12: Issue 10
Open access